Results 161 to 170 of about 5,299,620 (348)
Prosthetic Joint Infection Due to Staphylococcus lugdunensis [PDF]
Priya Sampathkumar +2 more
openalex +1 more source
Virus Enhanced Microrobots for Biofilm Eradication
Biofilms resist antimicrobials across medicine, industry, and environments. We present virus‐conjugated microrobots synthesized hydrothermally and magnetically actuated. Their motion and viral specificity enable targeted binding, penetration, and delivery, outperforming bare microrobots.
Jyoti +3 more
wiley +1 more source
Advances in our understanding of the bone and joint pathology caused by Staphylococcus aureus infection [PDF]
Sean P. Nair +2 more
openalex +1 more source
Probiotic‐Based Materials as Living Therapeutics
Recent advances in Engineered Living Materials are highlighted, integrating synthetic biology and advanced materials, with a focus on probiotic‐based therapeutics. Probiotic Living Materials hold great potential for biosensing, infection treatment, osteogenesis, wound healing, vaginal and gastrointestinal disorders, and cancer therapy. breakthroughs in
Laura Sabio +2 more
wiley +1 more source
Management of opportunist mycobacterial infections: Joint Tuberculosis Committee guidelines 1999 [PDF]
Subcommittee of the Joint Tuberculosis Committee of the British Thoracic Society
openalex +1 more source
A zinc‐coordinated nanogel assembly is reported that co‐delivers three enzymes to regulate glucose, oxidative stress, and oxygen levels. This system mimics natural enzyme cascades to reprogram the wound environment after pancreatectomy. In a post‐pancreatectomy mouse model, it accelerates healing by reducing infection, promoting blood vessel growth ...
Yedong Ma +9 more
wiley +1 more source
Fluconazole-impregnated beads in the management of fungal infection of prosthetic joints [PDF]
Aaron Bruce +3 more
openalex +1 more source
Bacteria‐Responsive Nanostructured Drug Delivery Systems for Targeted Antimicrobial Therapy
Bacteria‐responsive nanocarriers are designed to release antimicrobials only in the presence of infection‐specific cues. This selective activation ensures drug release precisely at the site of infection, avoiding premature or indiscriminate release, and enhancing efficacy.
Guillermo Landa +3 more
wiley +1 more source
Review Article: Paediatric Bone and Joint Infection [PDF]
N. Susan Stott
openalex +1 more source

